{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:16:41Z","timestamp":1790975801261,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2002,10,25]],"date-time":"2002-10-25T00:00:00Z","timestamp":1035504000000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2002,10]]},"abstract":"<jats:p>\n                    <jats:bold>Objective<\/jats:bold>\n                    .\u2014To evaluate the effects of three schemes of oral hormone replacement therapy (HRT) on migraine course in postmenopausal women.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods<\/jats:bold>\n                    .\u2014Thirty\u2010eight patients presenting for clinical evaluation of menopausal status and suffering from migraine were enrolled. The observational period lasted 7 months, during which women filled in a daily diary with the clinical features of headache attacks and analgesic use. We evaluated climacteric symptoms, anxiety and depression. After a 1\u2010month run\u2010in period, women were assigned to one of three regimens of HRT: estradiol hemihydrate 1 mg\/day plus norethisterone 0.5 mg\/day for 28 days, in a continuous combined scheme; oral conjugated estrogens 0.625 mg\/day for 28 days plus medroxyprogesterone acetate 10 mg\/day in the last 14 days, in a sequential continuous scheme; and estradiol valerate 2 mg\/day for 21 days plus cyproterone acetate 1 mg\/day from day 12 to 21 in a sequential cyclical scheme. Follow\u2010up evaluations were performed at 3 and 6 months.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    .\u2014During the run\u2010in period, the three subgroups of patients were similar as far as the features of migraine are concerned. Overall, a progressive increase in attack frequency (from 2.2\u2003\u2003\u00b1\u2003\u20031.0 to 3.8\u2003\u2003\u00b1\u2003\u20031.3,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001), days with headache (from 3.4\u2003\u2003\u00b1\u2003\u20031.3 to 4.9\u2003\u2003\u00b1\u2003\u20031.9,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001), and analgesic consumption (from 3.4\u2003\u2003\u00b1\u2003\u20031.3 to 5.6\u2003\u2003\u00b1\u2003\u20032.2,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001) was observed after 6 months. Duration of attacks decreased (from 18.1\u2003\u2003\u00b1\u2003\u20037.4 to 13.6\u2003\u2003\u00b1\u2003\u20034.2 hours,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003\u2003=\u2003\u2003.005), whereas severity worsened (from 1.9\u2003\u2003\u00b1\u2003\u20030.2 to 2.1\u2003\u2003\u00b1\u2003\u20030.2,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001). The increase in number of days with headache and number of analgesics used was smaller in the group receiving the continuous combined regimen than in the other two groups.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    .\u2014Although HRT typically will lead to some worsening of headache syndrome, estradiol hemihydrate plus norethisterone given in a combined continuous scheme was the regimen best tolerated by our patients.\n                  <\/jats:p>","DOI":"10.1046\/j.1526-4610.2002.02215.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T18:19:44Z","timestamp":1047406784000},"page":"924-929","source":"Crossref","is-referenced-by-count":66,"title":["Hormone Supplementation Differently Affects Migraine in Postmenopausal Women"],"prefix":"10.1111","volume":"42","author":[{"given":"F.","family":"Facchinetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. E.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Polatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,10,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.6.786"},{"issue":"20","key":"e_1_2_7_3_2","first-page":"1","article-title":"Headache and menstrually related disorders: in search of a consensus.","volume":"17","author":"Nappi G","year":"1997","journal-title":"Cephalalgia"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1975.hed1501036.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1993.hed3307385.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(93)90121-W"},{"key":"e_1_2_7_7_2","first-page":"827","article-title":"Early menopausal changes in bone mass and sex steroids.","volume":"60","author":"Johnston CC","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1999.019002124.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/13697130009167613"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(00)00215-2"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(05)70299-1"},{"key":"e_1_2_7_12_2","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain.","volume":"8","author":"Headache Classification Committee of the International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(76)90005-2"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(71)71480-7"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00857528"},{"key":"e_1_2_7_16_2","first-page":"37","article-title":"The role of sex hormone in headache.","volume":"42","author":"Silberstein SD","year":"1992","journal-title":"Neurology"},{"key":"e_1_2_7_17_2","first-page":"14","article-title":"Pharmacokinetics of estrogens and hormone replacement therapy.","volume":"4","author":"Kaufman JM","year":"1997","journal-title":"Eur Menopause J"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1999.276.4.H1355"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/09513590009167673"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0967-5868(98)90197-7"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.4.848"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.2.388"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1995.1504297.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/01674829609025660"},{"key":"e_1_2_7_25_2","first-page":"1","article-title":"Neurosteroids biosynthesis and function.","volume":"5","author":"Robel P","year":"1994","journal-title":"Trends in Neuroscience"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-4610.2002.02215.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-4610.2002.02215.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:20:11Z","timestamp":1762086011000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-4610.2002.02215.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["10.1046\/j.1526-4610.2002.02215.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-4610.2002.02215.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}